A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
SARASOTA, Fla., Nov. 9, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services company focused on expanding access to advanced fertility treatment worldwide with its INVOcell® medical device and the intravaginal culture...
An Introduction to NAYA Biosciences with CEO Dr. Daniel TeperManaging unprecedented medical innovation in an era of financial market volatilityIncreasing patient access to breakthrough treatments in oncology, regenerative medicine, and fertilitySARASOTA, Fla. and...
Post-merger, the combined company, operating under the name "NAYA Biosciences", will be dedicated to increasing patient access to life-transforming treatments in oncology, fertility, and regenerative medicineNAYA will seek to scale up profitable revenues in the...
This panel explores the dynamic realm of leading-edge technologies within the fertility market. Speakers include Steve Shum, CEO at INVO Bioscience and David Wolf, CEO at Hamilton Thorne Ltd. This KOL Panel was recorded during the Lytham Partners Fall 2023 Investor...
SARASOTA, Fla., Oct. 11, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture...
SARASOTA, Fla., Sept. 29, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company") today announced that its special meeting of shareholders on September 29, 2023 (the "Special Meeting") was convened and then adjourned, without conducting any business, in...
SARASOTA, Fla., Sept. 28, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture...
SARASOTA, Fla., Aug. 4, 2023 -- INVO Bioscience, Inc. (Nasdaq:INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture...
SARASOTA, Fla., March 27, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture...
SARASOTA, Fla., Jan. 5, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC")...